NOVEL CAUSE OF OVARIAN CANCER DRUG RESISTANCE IDENTIFIED
Dipanjan Chowdhury, PhD, and Panagiotis Konstantinopoulos, MD, PhD, identified a new resistance mechanism in which ovarian cancer cells turn off one of two competing DNA repair pathways and turn on the other that enables the tumor to resist platinum drugs and PARP inhibitors.